What low-molecular-weight protein is a cysteine protease inhibitor that can be used as a serum biomarker for detecting acute kidney injury?

Prepare for the Rosh Internal Medicine Exam with quizzes, flashcards, and multiple-choice questions, complete with hints and explanations. Get ready to excel on your exam!

Multiple Choice

What low-molecular-weight protein is a cysteine protease inhibitor that can be used as a serum biomarker for detecting acute kidney injury?

Explanation:
Cystatin C is a small, low-molecular-weight cysteine protease inhibitor produced by all nucleated cells at a constant rate and freely filtered by the glomerulus. It is then reabsorbed and degraded by the proximal tubule, so its serum concentration reflects GFR. When acute kidney injury occurs and GFR falls, cystatin C rises, often detecting dysfunction earlier than creatinine and with less dependence on muscle mass. The other options are not cysteine protease inhibitors, or are different low-molecular-weight proteins not describing the inhibitor in question (creatinine is a muscle metabolism byproduct; beta-2 microglobulin and NGAL are other biomarkers not described as cysteine protease inhibitors).

Cystatin C is a small, low-molecular-weight cysteine protease inhibitor produced by all nucleated cells at a constant rate and freely filtered by the glomerulus. It is then reabsorbed and degraded by the proximal tubule, so its serum concentration reflects GFR. When acute kidney injury occurs and GFR falls, cystatin C rises, often detecting dysfunction earlier than creatinine and with less dependence on muscle mass. The other options are not cysteine protease inhibitors, or are different low-molecular-weight proteins not describing the inhibitor in question (creatinine is a muscle metabolism byproduct; beta-2 microglobulin and NGAL are other biomarkers not described as cysteine protease inhibitors).

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy